Covestor’s Generate Biomedicines GENB Stock Holding History
Bought
Maintained
Sold
Other funds holding GENB
Covestor's GENB Position: Q3 2026 in Review
Covestor opened a new position in Generate Biomedicines (GENB) in Q3 2026: 21 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #2976 among its holdings.
109 funds tracked by Wall St. Rank hold GENB as of Q3 2026.
- Covestor held 21 shares of Generate Biomedicines worth $0 as of Q3 2026.
- Generate Biomedicines was a new Covestor position in Q3 2026.
- Generate Biomedicines made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2976 holding.
- 109 funds tracked by Wall St. Rank held Generate Biomedicines as of Q3 2026.
Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.